Rachael L. Fleurence, PhD, MSc, is currently serving as Senior Advisor to Dr. Francis Collins, the special projects advisor to the President and former acting science advisor to the President, at the White House. In this role, Dr. Fleurence is contributing to several scientific priorities for the Administration, including the development of a national elimination plan for Hepatitis C and the development of PCAST recommendations to improve patient safety and reduce medical harm in the United States. Dr. Fleurence otherwise serves as a Senior Advisor in the Immediate Office of the Director at the National Institutes of Health (NIH) and as the Special Assistant to the NIH Director for COVID-19 Diagnostics. Dr. Fleurence also served on the White House Pandemic Testing Board policy group and the White House Office of Science Technology Policy (OSTP) Pandemic Innovation Task Force. Prior to her role at the White House and NIH, Dr. Fleurence served as the inaugural Executive Director of the National Evaluation System for health Technology Coordinating Center (NESTcc), a public-private partnership between the U.S. Food and Drug Administration (FDA) and the medical device industry to improve evidence generation for medical devices. Dr. Fleurence is the recipient of several recent awards including the NIH Director’s Award for exceptional dedication and innovation in advancing COVID-19 testing and diagnostics efforts, and the Health and Human Services Secretary’s award for Distinguished Service as a member of the Rapid Acceleration of COVID-19 Diagnostics team.